MRK Merck & Co., Inc. logo

MRK Merck & Co., Inc.

Healthcare
$122.41+5.64%ClosedMarket Cap: $302.33B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

16.17

PEG

2.43

P/B

6.60

P/S

4.61

EV/EBITDA

15.25

DCF Value

$218.64

FCF Yield

4.7%

Div Yield

2.7%

Margins & Returns

Gross Margin

75.9%

Operating Margin

27.6%

Net Margin

13.6%

ROE

17.9%

ROA

6.9%

ROIC

13.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$16.29B$-4.24B$
Q4 null$16.32B$2.96B$
FY null$64.93B$18.25B$
Q3 null$17.18B$5.79B$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$129.31

Target (Median)

$133.00

Target Range

$100.00 - $150.00

4 Strong Buy15 Buy10 Hold0 Sell0 Strong Sell
Wells FargoOverweight
2026-05-01
UBSBuy
2026-04-13
JP MorganOverweight
2026-04-06
RBC CapitalOutperform
2026-03-30
CitigroupNeutral
2026-03-20

Trading Activity

Insider Trades

View All
Zachary Jenniferofficer: EVP, General Counsel
SellThu May 07
Zachary Jenniferofficer: EVP, General Counsel
SellThu May 07
Williams David Michaelofficer: EVP,Chief Info&Digital Officer
SellThu May 07
Williams David Michaelofficer: EVP,Chief Info&Digital Officer
SellThu May 07
Litchfield Carolineofficer: EVP & CFO
SellThu May 07

Congress Trades

View All
Josh GottheimerBuy
Tue Mar 17

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

US

Exchange

Beta

0.20

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Peers